IR Meeting
FY2012
- Business Results Briefing Materials(2013/5/9)
- Presentation
＜Business Performance＞(829KB)
＜Development Pipeline＞(695KB) - Audio(Windows Media)
On-demand replay of the IR meeting
- Information Meeting(2013/2/21)
- Presentation
＜Becoming a “Company that Can Continue to Provide New Value”＞(3852KB) - Information Meeting＜Q&A＞(95KB)
- Audio
On-demand replay of the Information Meeting
- 3rd Quarter Results Presentation Materials(2013/2/1)
- Conference Call＜Presentation:Business Results＞(572KB)
- Conference Call＜Q&A＞(25KB)
- Audio
On-demand replay of Conference Call【It has been already finished】
- 2nd Quarter Results Presentation Materials(2012/10/29)
- Conference Call＜Presentation:Business Results＞(429KB)
- Conference Call＜Q&A＞(24KB)
- Audio
On-demand replay of Conference Call【It has been already finished】
- 1st Quarter Results Presentation Materials(2012/7/31)
- Conference Call＜Presentation:Business Results＞(210KB)
- Conference Call＜Q&A＞(43KB)
- Audio
On-demand replay of Conference Call【It has been already finished】
FY2011
- Business Results Briefing Materials(2012/5/10)
- Presentation
＜Business Performance＞(358KB)
＜Sales Strategy for a Big Jump＞(561KB) - Business Results Briefing＜Q&A＞(45KB)
- Audio(Windows Media)
On-demand replay of the IR meeting【It has been already finished】
- 3rd Quarter Results Presentation Materials(2012/1/31)
- Conference Call＜Presentation:Business Results＞(291KB)
- Conference Call＜Q&A＞(41KB)
- Audio
On-demand replay of Conference Call【It has been already finished】
- 2nd Quarter Results Presentation Materials(2011/10/31)
- Conference Call＜Presentation:Business Results＞(353KB)
- Conference Call＜Q&A＞(64KB)
- Audio
On-demand replay of Conference Call【It has been already finished】
- Medium-Term Management Plan Briefing Materials(2011/10/19)
- Presentation
＜Medium-Term Management Plan 11-15 ～New Value Creation＞(3,022KB)
- Briefing＜Q&A＞(50KB)
- Audio(Windows Media)
On-demand replay of the IR meeting【It has been already finished】
- Deutsche Securities Japan Pharmaceutical Conference 2011(2011/9/22)
- Presentation Material(1023KB)
- 1st Quarter Results Presentation Materials(2011/7/29)
- Conference Call＜Presentation:Business Results＞(935KB)
- Conference Call＜Q&A＞(44KB)
- Audio
On-demand replay of Conference Call【It has been already finished】
FY2010
- Business Results Briefing Materials(2011/5/12)
- Presentation
＜Business Performance＞(264KB)
＜Progress of the Development Pipeline＞(301KB) - Business Results Briefing＜Q&A＞(50KB)
- Audio(Windows Media)
On-demand replay of the IR meeting【It has been already finished】
- 3rd Quarter Results Presentation Materials(2011/1/28)
- Conference Call＜Presentation:Business Results Outline＞(133KB)
- Conference Call＜Q&A＞(45KB)
- Audio
On-demand replay of Conference Call【It has been already finished】
- R&D Meeting(2010/12/1)
- Presentation Material(605KB)
- R&D Meeting＜Q&A＞(24KB)
- Audio(Windows Media)
On-demand replay of the R&D meeting【It has been already finished】
- 2nd Quarter Business Results Briefing Materials(2010/11/1)
- Presentation
＜Business Performance＞(241KB)
＜Product Strategy & Development Pipeline＞(286KB) - Business Results Briefing＜Q&A＞(45KB)
- Audio(Windows Media)
On-demand replay of the IR meeting【It has been already finished】
- Deutsche Securities Japan Pharmaceutical Conference 2010(2010/9/29)
- Presentation Material(1302KB)
- 1st Quarter Results Presentation Materials(2010/7/29)
- Conference Call＜Presentation:Business Results Outline＞(143KB)
- Conference Call＜Q&A＞(23KB)
- Audio
On-demand replay of Conference Call【It has been already finished】
FY2009
- Business Results Briefing Materials(2010/5/14)
- Presentation
＜Business Performance＞(264KB)
＜Product Strategy & Development Pipeline＞(301KB) - Business Results Briefing＜Q&A＞(22KB)
- Audio(Windows Media)
On-demand replay of the IR meeting【It has been already finished】
- 3rd Quarter Results Presentation Materials(2010/1/28)
- Conference Call＜Presentation:Business Results Outline＞(113KB)
- Conference Call＜Q&A＞(25KB)
- Audio(Windows Media)
On-demand replay of Conference Call【It has been already finished】
- 2nd Quarter Business Results Briefing Materials(2009/11/4)
- Presentation
＜Business Performance and Medium-Term Management Plan 08-10 Updates＞(230KB)
＜Product Strategy & Development Pipeline＞(586KB) - Business Results Briefing＜Q&A＞(31KB)
- Audio(Windows Media)
On-demand replay of the IR meeting【It has been already finished】
- Deutsche Securities Japan Pharmaceutical Conference 2009(2009/9/30)
- Presentation Material(731KB)
- 1st Quarter Results Presentation Materials(2009/7/30)
- Conference Call＜Presentation:Business Results Outline＞(119KB)
- Conference Call＜Q&A＞(129KB)
- Audio
On-demand replay of Conference Call【It has been already finished】
- Information Meeting(2009/5/25)
- Presentation
＜Progress of Medium-Term Management Plan 08-10 and Growth Strategy of Remicade＞(620KB)
＜Development Pipeline & Key Development Projects＞(436KB) - Information Meeting＜Q&A＞(51KB)
- Audio
On-demand replay of the Information Meeting【It has been already finished】
FY2008
- Results Presentation Materials(2009/5/8)
- Conference Call＜Presentation:Business Results＞(264KB)
- Conference Call＜Q&A＞(52KB)
- Audio
On-demand replay of Conference Call【It has been already finished】
- Calyon：The 6th Annual CLSA Japan Forum(2009/2/24)
- Presentation Material：Dynamic Synergy for 2015(454KB)
- 3rd Quarter Results Presentation Materials(2009/1/29)
- Conference Call＜Presentation:Business Results Outline＞(151KB)
- Conference Call＜Q&A＞(142KB)
- Audio
On-demand replay of Conference Call【It has been already finished】
- 2nd Quarter Results Presentation Materials(2008/11/4)
- Business Results Briefing＜Presentation:Business Performance＞(281KB)
- Business Results Briefing＜Presentation:Development Pipeline＞(264KB)
- Business Results Briefing＜Q&A＞(48KB)
- Audio
On-demand replay of the IR meeting【It has been already finished】
- Deutsche Securities Japan Pharmaceutical Conference 2008(2008/9/29)
- Presentation Material(504KB)
- 1st Quarter Results Presentation Materials(2008/7/30)
- Conference Call＜Presentation:Business Results Outline＞(143KB)
- Conference Call＜Q&A＞(30KB)
- Audio
On-demand replay of Conference Call【It has been already finished】
FY2007
- Results Presentation Materials(2008/5/9)
- FY2007 Business Results Briefing＜Presentation:Business Performance＞(235KB)
- FY2007 Business Results Briefing＜Presentation:Medium-Term Management Plan＞(1037KB)
- FY2007 Business Results Briefing＜Presentation:Development pipeline＞(378KB)
- IR Meeting for FY2007 Business Results Briefing＜Q&A＞(31KB)
- Audio
On-demand replay of the IR meeting【It has been already finished】
- 3rd Quarter Results Presentation Materials(2008/1/29)
- Conference Call＜Presentation:Business Performance＞(133KB)
- Conference Call＜Q&A＞(21KB)
- Audio
On-demand replay of Conference Call【It has been already finished】
- Interim Results Presentation Materials(2007/11/5)
- Half-Year FY2007 Businessl Results＜Presentation:Business Performance＞(401KB)
- Half-Year FY2007 Businessl Results＜Presentation:R&D pipeline＞(307KB)
- IR Meeting for Half-Year FY2007 Businessl Results＜Q&A＞(15KB)
Presentation Material
(Published before October 1, 2007 by the company for the establishment of Mitsubishi Tanabe Phama Corporation is shown below.)
- Conference on the Merger of Tanabe Seiyaku Co., Ltd. and Mitsubishi Pharma Corporation(2007/5/16)
- Corporate Philosophy and Vision, Brand Mark, Business Management Goals and Other Policies of Mitsubishi Tanabe Pharma Corporation(45KB)
- Briefing on the Merger of Tanabe Seiyaku Co., Ltd. and Mitsubishi Pharma Corporation(769KB)
- Conference on the Merger of Tanabe Seiyaku Co., Ltd. and Mitsubishi Pharma Corporation (sound clip)
- Conference on the Merger of Tanabe Seiyaku Co., Ltd. and Mitsubishi Pharma Corporation<Q&A>(58KB)
- Joint Conference on the Merger of Tanabe Seiyaku Co., Ltd. and Mitsubishi Pharma Corporation(2007/2/2)
- Tanabe Seiyaku Co., Ltd. and Mitsubishi Pharma Corporation Enter into A Basic Agreement on Merge on October 1, 2007(162KB)
- Joint Conference on the Merger of Tanabe Seiyaku Co., Ltd. and Mitsubishi Pharma Corporation(220KB)
- Joint Conference on the Merger of Tanabe Seiyaku Co., Ltd. and Mitsubishi Pharma Corporation <Q&A>(31KB)
